Literature DB >> 18345000

A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia.

Ian M Morison1, Elisabeth M Cramer Bordé, Emma J Cheesman, Pak Leng Cheong, Andrew J Holyoake, Serge Fichelson, Robert J Weeks, Alexandra Lo, Stefan M K Davies, Sigurd M Wilbanks, Robert D Fagerlund, Mathew W Ludgate, Fernanda M da Silva Tatley, Melanie S A Coker, Nicholas A Bockett, Gillian Hughes, Diana A Pippig, Mark P Smith, Claude Capron, Elizabeth C Ledgerwood.   

Abstract

We report the first identified mutation in the gene encoding human cytochrome c (CYCS). Glycine 41, invariant throughout eukaryotes, is substituted by serine in a family with autosomal dominant thrombocytopenia caused by dysregulated platelet formation. The mutation yields a cytochrome c variant with enhanced apoptotic activity in vitro. Notably, the family has no other phenotypic indication of abnormal apoptosis, implying that cytochrome c activity is not a critical regulator of most physiological apoptosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18345000     DOI: 10.1038/ng.103

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  53 in total

1.  Platelet senescence and phosphatidylserine exposure.

Authors:  Swapan Kumar Dasgupta; Eduardo Rios Argaiz; Jose Emmanel Chedid Mercado; Hector Omar Elizondo Maul; Jorge Garza; Ana Bety Enriquez; Hanan Abdel-Monem; Anthony Prakasam; Michael Andreeff; Perumal Thiagarajan
Journal:  Transfusion       Date:  2010-10-04       Impact factor: 3.157

Review 2.  Cytochrome c: the Achilles' heel in apoptosis.

Authors:  A V Kulikov; E S Shilov; I A Mufazalov; V Gogvadze; S A Nedospasov; B Zhivotovsky
Journal:  Cell Mol Life Sci       Date:  2011-12-17       Impact factor: 9.261

Review 3.  Piecing together the humoral and cellular mechanisms of immune thrombocytopenia.

Authors:  Lisa J Toltl; Ishac Nazi; Reza Jafari; Donald M Arnold
Journal:  Semin Thromb Hemost       Date:  2011-11-18       Impact factor: 4.180

Review 4.  Understanding platelet generation from megakaryocytes: implications for in vitro-derived platelets.

Authors:  Xiuli Sim; Mortimer Poncz; Paul Gadue; Deborah L French
Journal:  Blood       Date:  2016-01-19       Impact factor: 22.113

Review 5.  Mitochondrial Diseases Part I: mouse models of OXPHOS deficiencies caused by defects in respiratory complex subunits or assembly factors.

Authors:  Alessandra Torraco; Susana Peralta; Luisa Iommarini; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-02-04       Impact factor: 4.160

6.  The regulation of proplatelet production.

Authors:  Amy E Geddis
Journal:  Haematologica       Date:  2009-06       Impact factor: 9.941

Review 7.  Megakaryopoiesis and platelet production: insight into hematopoietic stem cell proliferation and differentiation.

Authors:  Tianyu Guo; Xuejun Wang; Yigong Qu; Yu Yin; Tao Jing; Qing Zhang
Journal:  Stem Cell Investig       Date:  2015-02-14

8.  Naturally Occurring A51V Variant of Human Cytochrome c Destabilizes the Native State and Enhances Peroxidase Activity.

Authors:  Haotian Lei; Bruce E Bowler
Journal:  J Phys Chem B       Date:  2019-10-14       Impact factor: 2.991

9.  Remote Perturbations in Tertiary Contacts Trigger Ligation of Lysine to the Heme Iron in Cytochrome c.

Authors:  Jie Gu; Dong-Woo Shin; Ekaterina V Pletneva
Journal:  Biochemistry       Date:  2017-05-31       Impact factor: 3.162

10.  Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness.

Authors:  Chantal Lagresle-Peyrou; Emmanuelle M Six; Capucine Picard; Frédéric Rieux-Laucat; Vincent Michel; Andrea Ditadi; Corinne Demerens-de Chappedelaine; Estelle Morillon; Françoise Valensi; Karen L Simon-Stoos; James C Mullikin; Lenora M Noroski; Céline Besse; Nicolas M Wulffraat; Alina Ferster; Manuel M Abecasis; Fabien Calvo; Christine Petit; Fabio Candotti; Laurent Abel; Alain Fischer; Marina Cavazzana-Calvo
Journal:  Nat Genet       Date:  2008-11-30       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.